Status:
COMPLETED
Photobiomodulation and Glass Ionomer Sealant as Complementary Treatment for Hypersensitivity in Molars With MIH
Lead Sponsor:
University of Nove de Julho
Conditions:
Hypomineralization Molar Incisor
Eligibility:
All Genders
6-12 years
Phase:
PHASE1
PHASE2
Brief Summary
Introduction: Photobiomodulation (PBM) shows promising results for the complementary treatment of dentin hypersensitivity; however, few studies have evaluated this treatment specifically for teeth aff...
Eligibility Criteria
Inclusion
- Healthy individuals (ASA I);
- Children aged 6 to 12 years with at least one permanent first molar affected by MIH grades 3 and 4 (a and b) according to the MIH Treatment Needs Index (TNI), and with hypersensitivity score 2 or higher on the visual analog scale (VAS);
- Molars with fractures and without pulp involvement or active caries;
- Molars with eruption of the entire occlusal surface and at least one-third of the vestibular surface.
Exclusion
- Molars with hypersensitivity caused by carious lesions were excluded to avoid diagnostic confusion with pulpitis;
- Teeth that had undergone desensitizing treatments in the previous three months, except for daily use toothpaste;
- Those with fixed orthodontic appliances; Patients who experienced discomfort during the hypersensitivity test, or those unable to tolerate the procedure were also excluded.
Key Trial Info
Start Date :
July 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05370417
Start Date
July 19 2022
End Date
March 12 2024
Last Update
October 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sandra Bussadori
São Paulo, São Paulo, Brazil, 01504-001